A Medication-wide Association Study (MWAS) on Repurposed Drugs for COVID-19 with Pre-pandemic Prescription Medication Exposure and Pregnancy Outcomes

Overview

Journal Sci Rep

Specialty Science

Date 2022 Nov 26

PMID 36433981

Authors

Lena Davidson

Silvia P Canelon

Mary Regina Boland

Affiliations

Soon will be listed here.

Abstract

Information on effects of medication therapies during pregnancy is lacking as pregnant patients are often excluded from clinical trials. This retrospective study explores the potential of using electronic health record (EHR) data to inform safety profiles of repurposed COVID medication therapies on pregnancy outcomes using pre-COVID data. We conducted a medication-wide association study (MWAS) on prescription medication exposures during pregnancy and the risk of cesarean section, preterm birth, and stillbirth, using EHR data between 2010-2017 on deliveries at PennMedicine. Repurposed drugs studied for treatment of COVID-19 were extracted from ClinicalTrials.gov (n = 138). We adjusted for known comorbidities diagnosed within 2 years prior to birth. Using previously developed medication mapping and delivery-identification algorithms, we identified medication exposure in 2,830 of a total 63,334 deliveries; from 138 trials, we found 31 medications prescribed and included in our cohort. We found 21 (68%) of the 31 medications were not positively associated with increased risk of the outcomes examined. With caution, these medications warrant potential for inclusion of pregnant individuals in future studies, while drugs found to be associated with pregnancy outcomes require further investigation. MWAS facilitates hypothesis-driven evaluation of drug safety across all prescription medications, revealing potential drug candidates for further research.

References

Mitchell A, Gilboa S, Werler M, Kelley K, Louik C, Hernandez-Diaz S . Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011; 205(1):51.e1-8. PMC: 3793635. DOI: 10.1016/j.ajog.2011.02.029. View

Davidson L, Canelon S, Boland M . Medication-Wide Association Study Using Electronic Health Record Data of Prescription Medication Exposure and Multifetal Pregnancies: Retrospective Study. JMIR Med Inform. 2022; 10(6):e32229. PMC: 9214620. DOI: 10.2196/32229. View

Sen A, Vardaxis I, Lindqvist B, Brumpton B, Strand L, Bakken I . Systematic assessment of prescribed medications and short-term risk of myocardial infarction - a pharmacopeia-wide association study from Norway and Sweden. Sci Rep. 2019; 9(1):8257. PMC: 6547702. DOI: 10.1038/s41598-019-44641-1. View

Haram K, Mortensen J, Morrison J . Tocolysis for acute preterm labor: does anything work. J Matern Fetal Neonatal Med. 2014; 28(4):371-8. DOI: 10.3109/14767058.2014.918095. View

Di Toro F, Gjoka M, Lorenzo G, De Santo D, De Seta F, Maso G . Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect. 2020; 27(1):36-46. PMC: 7605748. DOI: 10.1016/j.cmi.2020.10.007. View

Figueiro-Filho E, Yudin M, Farine D . COVID-19 during pregnancy: an overview of maternal characteristics, clinical symptoms, maternal and neonatal outcomes of 10,996 cases described in 15 countries. J Perinat Med. 2020; 48(9):900-911. DOI: 10.1515/jpm-2020-0364. View

Janssen O, Thompson M, Milburn S, Green R, Wagner B, Bianco A . The impact of perinatal severe acute respiratory syndrome coronavirus 2 infection during the peripartum period. Am J Obstet Gynecol MFM. 2020; 3(1):100267. PMC: 7574715. DOI: 10.1016/j.ajogmf.2020.100267. View

Baud D, Greub G, Favre G, Gengler C, Jaton K, Dubruc E . Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection. JAMA. 2020; 323(21):2198-2200. PMC: 7193526. DOI: 10.1001/jama.2020.7233. View

Brandt J, Hill J, Reddy A, Schuster M, Patrick H, Rosen T . Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes. Am J Obstet Gynecol. 2020; 224(4):389.e1-389.e9. PMC: 7518835. DOI: 10.1016/j.ajog.2020.09.043. View

10.

Bookstaver P, Bland C, Griffin B, Stover K, Eiland L, McLaughlin M . A Review of Antibiotic Use in Pregnancy. Pharmacotherapy. 2015; 35(11):1052-62. DOI: 10.1002/phar.1649. View

11.

Coloma P, Schuemie M, Trifiro G, Furlong L, van Mulligen E, Bauer-Mehren A . Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system. PLoS One. 2013; 8(8):e72148. PMC: 3756064. DOI: 10.1371/journal.pone.0072148. View

12.

Mehta H, Ehrhardt S, Moore T, Segal J, Alexander G . Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis. BMJ Open. 2020; 10(6):e039978. PMC: 7286283. DOI: 10.1136/bmjopen-2020-039978. View

13.

Ryan P, Madigan D, Stang P, Schuemie M, Hripcsak G . Medication-wide association studies. CPT Pharmacometrics Syst Pharmacol. 2014; 2:e76. PMC: 4026636. DOI: 10.1038/psp.2013.52. View

14.

Einav S, Ippolito M, Cortegiani A . Inclusion of pregnant women in clinical trials of COVID-19 therapies: what have we learned?. Br J Anaesth. 2020; 125(3):e326-e328. PMC: 7261425. DOI: 10.1016/j.bja.2020.05.020. View

15.

Jin X, Ding C, Hunter D, Gallego B . Effectiveness of vitamin D supplementation on knee osteoarthritis - A target trial emulation study using data from the Osteoarthritis Initiative cohort. Osteoarthritis Cartilage. 2022; 30(11):1495-1505. DOI: 10.1016/j.joca.2022.06.005. View

16.

Challa A, Lavieri R, Lippmann E, Goldstein J, Bastarache L, Pulley J . EHRs could clarify drug safety in pregnant people. Nat Med. 2020; 26(6):820-821. DOI: 10.1038/s41591-020-0925-1. View

17.

Lokken E, Huebner E, Taylor G, Hendrickson S, Vanderhoeven J, Kachikis A . Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol. 2021; 225(1):77.e1-77.e14. PMC: 7838012. DOI: 10.1016/j.ajog.2020.12.1221. View

18.

Amici C, Di Caro A, Ciucci A, Chiappa L, Castilletti C, Martella V . Indomethacin has a potent antiviral activity against SARS coronavirus. Antivir Ther. 2007; 11(8):1021-30. View

19.

Andersson N, Olsen R, Traerup Andersen J . Association between use of macrolides in pregnancy and risk of major birth defects: nationwide, register based cohort study. BMJ. 2021; 372:n107. PMC: 7873722. DOI: 10.1136/bmj.n107. View

20.

Liu C, Liu C, Wang Q, Zhang Z . Supplementation of folic acid in pregnancy and the risk of preeclampsia and gestational hypertension: a meta-analysis. Arch Gynecol Obstet. 2018; 298(4):697-704. PMC: 6153594. DOI: 10.1007/s00404-018-4823-4. View